LuciAsc 40mg is a targeted therapy used in the treatment of chronic myeloid leukemia especially in patients who do not respond to standard treatments. It provides a novel mechanism to control cancer cell growth. This medicine is used across the United Kingdom, United States, Australia, Singapore and Philippines in advanced oncology care. LuciAsc helps improve disease control and offers an alternative option for resistant cases.
Active Ingredient
Asciminib is a STAMP inhibitor that specifically targets the ABL myristoyl pocket. It belongs to a new class of targeted therapies designed for precision cancer treatment.
Uses of LuciAsc 40mg
• Treatment of chronic myeloid leukemia
• Management of resistant leukemia cases
• Relief from disease progression
• Support for targeted therapy
How LuciAsc 40mg Works
Asciminib works by binding to a specific site on the BCR ABL protein preventing its activity. This action blocks signals that cause cancer cell growth leading to reduced tumor burden and improved control of leukemia.
How to Use LuciAsc 40mg
1. Take as prescribed by your doctor
2. Swallow whole with water
3. Follow consistent timing daily
Possible Side Effects
• Fatigue
• Headache
• Nausea
• Joint pain
Precautions
• Monitor blood counts
• Inform doctor about liver conditions
• Avoid during pregnancy
Safety Information
LuciAsc should be taken only under medical supervision. Follow all instructions carefully and attend regular monitoring appointments.
Storage
• Store at room temperature
• Keep away from moisture
• Keep out of reach of children
